Products

WellDoc BlueStar
WellDoc
Cardiology AI
WellDoc BlueStar is an FDA-cleared, AI-powered digital health solution for chronic disease management, offering personalized coaching and insights for conditions like diabetes, hypertension, and heart failure.

See all 1 product →

About WellDoc

WellDoc is an AI-powered health technology leader dedicated to transforming cardiometabolic care through its clinically validated digital health platform. The company’s solutions are designed to provide a unified experience for individuals managing a spectrum of conditions, including prediabetes, type 1 and type 2 diabetes, obesity (with GLP-1 support), hypertension, heart failure, diabetes in pregnancy, sleep apnea, chronic kidney disease (CKD), and metabolic dysfunction-associated steatohepatitis (MASH), alongside support for weight management and mental well-being.

The WellDoc platform leverages advanced, healthcare-ready AI, backed by over 100 peer-reviewed clinical publications, 11 FDA clearances for diabetes functionality, and 60 patents, to deliver personalized, predictive, and actionable insights. It integrates seamlessly with over 400 devices and data sources, including continuous glucose monitors (CGMs), blood pressure monitors, and activity trackers, and can also integrate with electronic health record (EHR) systems. This comprehensive data aggregation and analysis enable continuous, personalized support that extends care beyond traditional office visits, empowering both patients and care teams with real-time information and guidance.

For physicians, WellDoc’s platform offers a robust tool to enhance chronic disease management. It provides secure access to patient health data and actionable insights through a web-based portal, facilitating informed clinical decisions, interventions, and population health management between appointments. The AI-driven coaching and educational content aim to promote healthy behaviors and adherence to treatment plans, ultimately leading to improved patient outcomes such as A1C reduction and blood pressure control. The company’s commitment to clinical rigor and responsible AI development, including its dedicated AI Lab and academic partnerships, underscores its focus on delivering trusted and effective digital health solutions.

Focus Areas

Type 1 Diabetes Type 2 Diabetes Pre-diabetes Gestational Diabetes Hypertension Heart Failure Weight Management Obesity Management GLP-1 Support Mental Well-being Sleep Apnea Chronic Kidney Disease (CKD) Metabolic Dysfunction-Associated Steatohepatitis (MASH)

Business Intelligence

Key InvestorsSamsung Ventures, Merck Global Health Innovation Fund, Adage Capital Management, Excel Venture Management, Alexandria Venture Investments, Hudson River Capital Partners, Windham Venture Partners, Johnson & Johnson Innovation, DPDigiTx Partners
Partnershipsb.well Connected Health, Databricks, Dexcom, Humana, CVS Health, Eli Lilly, Johns Hopkins University Center for Digital Health and AI (CDHAI), Vellore Institute of Technology, CMS Health Tech Ecosystem Initiative
AcquisitionsNone
TechnologyAI-powered, healthcare-ready AI, proprietary algorithms, clinical-first training, device-agnostic, integrates with 400+ devices and data sources (CGMs, blood glucose monitors, blood pressure cuffs, weight scales, fitness trackers, labs, pharmacies), EHR integration, cloud-native (Databricks Data Intelligence Platform), specialized Large Sensor Models (LSMs), novel hybrid machine learning, transformer-based approaches, API/SDK integration
FDA Clearances11 cleared products (estimated)

What Physicians Need to Know

Type 1 & Type 2 Diabetes
WellDoc offers an FDA-cleared AI solution, BlueStar, for both Type 1 and Type 2 Diabetes management. It provides personalized coaching, advanced insulin management tools (including basal, bolus, and premixed insulin titration), and seamless integration with Continuous Glucose Monitoring (CGM) devices. The platform supports medication adherence and has demonstrated significant A1C improvements.
Pre-diabetes
The platform actively addresses pre-diabetes by focusing on insulin resistance and fostering tailored behavioral and nutritional changes to help prevent the onset of Type 2 Diabetes.
Gestational Diabetes
WellDoc provides education and support for diabetes in pregnancy, offering adaptive targets and insights throughout each trimester, with a focus on both maternal and fetal health. Note: While the general Welldoc App is not indicated for gestational diabetes, a separate non-FDA cleared software, 'Welldoc for Diabetes in Pregnancy and Insulin Pump Users,' is available to help manage this condition.
Hypertension
WellDoc offers integrated heart health support, transforming isolated blood pressure readings into actionable insights. It provides personalized coaching that combines blood pressure management with nutrition (e.g., DASH diet), weight, and activity for a holistic view of health.
Heart Failure
The platform provides proactive support for heart failure, including sensitive detection of specific early warning signs and weight coaching to help prevent fluid retention. Educational tools are integrated to support overall heart health.
Weight & Obesity Management
WellDoc delivers a comprehensive weight and obesity management solution, with or without GLP-1 medications. It features AI-driven coaching, personalized support for the entire weight journey (titration, maintenance, discontinuation), medication reminders, side-effect tracking, and robust nutritional guidance. Predictive AI models can forecast weight loss outcomes with high accuracy.
GLP-1 Support
The platform is built for the GLP-1 era, offering integrated and intelligent support for GLP-1 users. This includes medication reminders, personalized trackers, weight management, and education on managing treatment, dosing, and symptoms. It emphasizes combining GLP-1s with robust behavior change programs for sustainable results.
Mental Well-being
WellDoc integrates mental well-being support into its multi-condition platform, recognizing its importance in overall chronic disease management.
Sleep Apnea
Sleep apnea is supported as part of WellDoc's comprehensive chronic care platform, contributing to a holistic approach to patient health.
Chronic Kidney Disease (CKD)
WellDoc addresses CKD as a specialty condition, extending its support beyond traditional cardiometabolic care.
Metabolic Dysfunction-Associated Steatohepatitis (MASH)
MASH is included as a specialty condition within WellDoc's broad platform, demonstrating its capability to expand into complex therapeutic areas.
Physician Tip

WellDoc stands out for physicians due to its **FDA-cleared AI solution** (BlueStar) for diabetes, offering advanced insulin management and CGM integration. The platform provides **actionable, AI-driven insights** and decision support, transforming fragmented patient data into clear reports for clinical review, which can streamline care and reduce administrative burden. Its **clinically validated outcomes** (e.g., A1C reduction, blood pressure improvement, weight loss) are backed by over 100 peer-reviewed publications and 11 FDA 510(k) clearances, building trust in its efficacy. The **comprehensive, multi-condition management** approach allows for a holistic view of patients with interconnected chronic conditions, facilitating integrated care. Furthermore, its **remote patient monitoring (RPM) capabilities** and broad device connectivity enable continuous patient oversight outside of traditional office visits, potentially allowing for RPM reimbursement.

WellDoc's platform is highly device-agnostic, connecting to over 400 devices and data sources, including continuous glucose monitors (CGM), blood glucose meters (BGM), blood pressure monitors, weight scales, and smart wearables. It also integrates with pharmacies and patient portals to import medications and lab results automatically, providing a comprehensive '360-degree view' of the patient's health. The underlying technology leverages Databricks for aggregating diverse data, enabling the AI-driven real-time digital coaching to provide personalized, data-driven recommendations.

Products by WellDoc

1 product in the directory

WellDoc BlueStar
WellDoc
Cardiology AI
WellDoc BlueStar is an FDA-cleared, AI-powered digital health solution for chronic disease management, offering personalized coaching and insights for conditions like diabetes, hypertension, and heart failure.

What the Web Says

WellDoc is a company that offers an AI-powered digital health platform focused on cardiometabolic care, including diabetes, obesity, hypertension, and heart failure. The company is recognized for its strong workplace culture and has received awards as a 'Great Place to Work' in healthcare. Product reviews indicate that the app can be helpful for managing health data and offers a wide variety of health-related topics. However, some users have reported issues with the app's user interface and bugs, particularly concerning data syncing and accuracy.

Overall: Mixed

Strengths

  • Syncs to multiple devices and EMR services, making data management easy.
  • Provides quick access to a wide variety of health and well-being topics and conditions.
  • Helps users see evidence-based practices for specific conditions and diseases.
  • Strong company culture with a focus on collaboration and growth.
  • Employees feel welcome and that people care about each other.
  • Opportunities for innovation, growth, and leadership within the company.

Limitations

  • User interface is not the best and can seem outdated.
  • Software can be a little hard to grasp and usability could be improved.
  • App has been reported as buggy, purging meal data and incorrectly marking medications as taken.
  • Issues with direct syncing to Fitbit, requiring a cumbersome workaround that strips data.
  • Some alerts in the app can be excessive for users who are already diligent with their health management.
  • Lack of transparency and communication issues between internal teams and clients reported in some employer reviews.

Based on reviews from: G2, Reddit, Great Place To Worku00ae, Indeed.com, Business Wire, Apple App Store, Capterra

Last updated: 2026-07-19

Videos

News, demos, and interviews about WellDoc.

Loading videos...

Videos load interactively. If none appear, search YouTube for WellDoc →

View all on YouTube

Press & Coverage

Welldoc
Senseonics and Welldoc Partner to Develop Next-Generation App for Eversenseu00ae 365
Welldoc and Senseonics have partnered to create a new app for Eversenseu00ae 365, aiming to advance digital health solutions. This collaboration focuses on developing next-generation technology for continuous glucose monitoring.
2026-06
Business Wire
Welldoc Recognized by Modern Healthcare as One of the Best Places to Work in Healthcare for Second Consecutive Year
For the second year in a row, Welldoc has been named one of Modern Healthcare's Best Places to Work, highlighting its commitment to employee well-being and innovative health tech. The recognition reflects a strong corporate culture focused on clinical rigor and scalable health solutions.
2026-06
Business Wire
Welldoc Named u201cBest Overall Digital Health Companyu201d For Fourth Consecutive Year in 10th Annual MedTech Breakthrough Awards Program
Welldoc has received the 'Best Overall Digital Health Company' award for the fourth consecutive year from MedTech Breakthrough, acknowledging its leadership and innovation in digital health. The company was recognized for its AI-powered health technology solutions.
2026-05
Welldoc
Welldoc Brings AI-Powered Cardiometabolic Care to 68 Million Medicare Beneficiaries Through the ACCESS Model and Medicare App Library
Welldoc has been selected by CMS to participate in the ACCESS Model and be included in the new Medicare App Library, extending its AI-powered cardiometabolic care to 68 million Medicare beneficiaries. This initiative aims to transform chronic disease management in Medicare.
2026-04
Business Wire
Welldoc Partners with b.well to Advance Interoperability and Seamless Patient Health Record Access
Welldoc announced a strategic partnership with b.well Connected Health to enhance interoperability and patient health record access. This collaboration will provide Welldoc with access to patient-authorized health data at an unprecedented scale.
2026-04
Business Wire
Welldoc Bridges the Insulin Dosing Gap with New Real-World Evidence
Welldoc has released new real-world evidence demonstrating improved time in range (TIR) for individuals using its Continuous Glucose Monitor (CGM)-informed insulin bolus calculator. This evidence supports the effectiveness of their AI-powered solution in managing insulin dosing.
2026-03
Welldoc
Welldoc Submits 510(k) to FDA for CGM-Informed Glucose Prediction Feature
Welldoc submitted a 510(k) premarket notification to the FDA for its CGM-Informed Glucose Prediction Feature, building on its 11 prior FDA 510(k) clearances. This feature aims to predict glucose values up to two hours in advance for individuals with type 2 diabetes not using insulin.
2026-01
Welldoc
Welldoc Expands AI-Powered Cardiometabolic Platform to Include Chronic Kidney Disease and MASH Support
Welldoc announced the expansion of its AI-powered cardiometabolic platform to offer comprehensive support for managing chronic kidney disease (CKD) and metabolic dysfunction-associated steatohepatitis (MASH). This expansion reinforces Welldoc's commitment to holistic, evidence-based AI-driven solutions.
2025-10

Frequently Asked Questions

WellDoc's AI-powered platform provides multi-condition digital coaching across Type 1 and Type 2 diabetes, pre-diabetes, gestational diabetes, hypertension, heart failure, weight and obesity management (with GLP-1 support), chronic kidney disease (CKD), and MASH. It also integrates support for mental well-being and sleep apnea, offering a holistic approach to chronic care.
WellDoc's BlueStaru00ae is an FDA-cleared digital health solution for Type 1 and Type 2 diabetes, with 11 510(k) clearances for diabetes functionality. The platform is backed by over 100 peer-reviewed clinical publications demonstrating outcomes such as A1C reduction, blood pressure reduction, and weight loss.
WellDoc offers integrated, AI-driven support for individuals on GLP-1 medications, including medication reminders, personalized trackers, and education on managing treatment, dosing, and side effects. The platform provides comprehensive weight management support throughout the entire journey, whether or not a patient is using GLP-1s.
The WellDoc platform features a care management portal that connects clinical teams to diverse data streams and new insights, enabling oversight of individuals' health between doctor visits. It integrates with EHR systems and over 400 devices, providing easy-to-digest alerts, trends, and reports to support clinical interventions and decisions.
WellDoc operates with clinical-grade security, adhering to a rigorous quality management system aligned with Class II Medical Devices, MDSAP/ISO 13485 standards. It is HITRUST r2 and SOC2 Type 2 certified, fully compliant with HIPAA and GDPR, and employs enterprise-grade security architecture with data encryption and intrusion detection systems.
WellDoc partners with life sciences companies, health plans, health systems, and employers, including strategic collaborations with b.well Connected Health and Databricks. The company, founded in 2005, has raised over $82 million in funding, is a participant in the CMS Health Tech Ecosystem initiative, and has been recognized as a 'Best Overall Digital Health Company' for two consecutive years, indicating strong market position and stability.
While specific pricing models are typically discussed directly with WellDoc, the platform has demonstrated significant cost savings for health plans and employers. Research indicates estimated savings of $3,048-$3,252 per person with diabetes over two years and a 55% decrease in costs from baseline in some programs.

Investors

Who's funded WellDoc.

Related Companies

CAIMed, the Lower Saxony Center for Artificial Intelligence and Causal Methods in Medicine, is a research institution dedicated to advancing personalized healthcare through innovative AI and causal methodologies. The center aims to address widespread diseases such as cancer, cardiovascular diseases, and infections by linking research data, clinical data, and patient care data. This integrated approach, […]

Autoderm is a health technology company that provides a CE-marked AI dermatology screening API designed to analyze smartphone photos for various skin conditions. The company’s AI models are trained on a proprietary database of amateur smartphone images of skin diseases and are accessible via an API that can be integrated into various platforms, including electronic […]

OCTA is an AI-powered finance automation platform that aims to streamline financial operations and accelerate cash flow for businesses, particularly SMEs and enterprises in the Middle East, with a strong presence in the UAE and Saudi Arabia. The platform utilizes AI agents to automate tasks across the entire contract-to-cash cycle, including contract creation, e-signing, invoicing, […]

Skin Analytics is a British health technology company dedicated to the early and accurate diagnosis of skin cancer, aiming to reduce mortality from the disease. They achieve this through their flagship product, DERM, an AI-powered medical device. DERM is designed to provide dermatologist-quality skin cancer assessments, making them more accessible and reducing the burden on […]

MedTalk AI is an Australian-based healthcare AI company focused on streamlining clinical documentation for physicians and other healthcare professionals. The company’s flagship product is an ambient AI medical scribe that listens to real clinical conversations and converts them into structured, accurate notes in real-time. This technology aims to free clinicians from the burden of manual […]

allergoSMART is a healthcare AI company that offers the world’s first AI-based complete solution for personalized mite allergen avoidance. The company’s system, allergoSMART, provides a unique AI digital solution for individuals with dust mite allergies, combining targeted prevention and treatment through comprehensive home environment optimization. [3] It integrates symptom tracking, telemedicine, and air purification into […]

AI Tool Finder
AI-powered search. Results may not be comprehensive.